Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Carson Veldstra

1PUBLICATIONS
18CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jun 02, 2023
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma.

Vivek Subbiah, Sant P Chawla, Anthony P Conley

Pageof 1

Frequent Collaborators

1 joint publications

Vivek Subbiah

1 joint publications

Sant P Chawla

1 joint publications

Anthony P Conley

1 joint publications

Breelyn A Wilky

1 joint publications

Anthony Tolcher

1 joint publications

Nehal J Lakhani

1 joint publications

David Berz

1 joint publications

Vasily Andrianov

1 joint publications

William Crago

1 joint publications

Monica Holcomb

Frequent Collaborators

1 joint publications

Vivek Subbiah

1 joint publications

Sant P Chawla

1 joint publications

Anthony P Conley

1 joint publications

Breelyn A Wilky

Top Related Videos

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma
12:44

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma

Published on : Jul 17, 2013

25.6K
See more related videos

Top Related Videos

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma
12:44

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma

Published on : Jul 17, 2013

25.6K
See more related videos